P1447: INFERIOR OUTCOMES OF EU VS. US PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA AFTER CD19 CAR T-CELL THERAPY ARE IMPACTED BY BASELINE RISK FACTORS AND CAR PRODUCT CHOICE

P1447: INFERIOR OUTCOMES OF EU VS. US PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA AFTER CD19 CAR T-CELL THERAPY ARE IMPACTED BY BASELINE RISK FACTORS AND CAR PRODUCT CHOICE

书目详细资料
Main Authors:	V. Bücklein, A. Perez, G. Iacoboni, K. Rejeski, U. Holtick, O. Penack, S. Kharboutli, V. Blumenberg, J. Ackermann, L. Frölich, G. Johnson, K. Patel, B. Arciola, C. Schmidt, O. Albanyan, P. Gödel, E. Hoster, L. Bullinger, A. Mackensen, F. Locke, M. von Bergwelt, P. Barba, M. D. Jain, M. Subklewe
格式:	文件
语言:	English
出版:	Wiley 2022-06-01
丛编:	HemaSphere
在线阅读:	http://journals.lww.com/10.1097/01.HS9.0000848644.19354.c7

相似书籍

Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use
由: Veit Bücklein, et al.
出版: (2023-08-01)

P1458: PATTERNS OF LONG-TERM HEMATOPOIETIC RECOVERY IMPACT SURVIVAL OUTCOMES AFTER CD19-DIRECTED CAR T-CELL THERAPY FOR R/R LBCL
由: K. Rejeski, et al.
出版: (2022-06-01)

P1438: PROCALCITONIN IS ELEVATED IN SEVERE INFECTIONS AFTER CD19 CAR-T IN R/R B-NHL AND ENABLES DISCRIMINATION OF EARLY INFECTIONS FROM CRS – PARTICULARLY IN COMBINATION WITH THE CAR-HEMATOTOX SCORE
由: K. Rejeski, et al.
出版: (2022-06-01)

P1445: MYTCELL®: AN INTERACTIVE SMARTPHONE APPLICATION FOR CARS AND BITES INCREASES GUIDELINE ACCESSIBILITY AND REDUCES TIME TO APPLY EVIDENCE-BASED PATIENT CARE
由: V. Blumenberg, et al.
出版: (2022-06-01)

PB2210: FAVORABLE OUTCOME AFTER SECOND CD19 CAR T INFUSION OF AN IDENTICAL PRODUCT: HOST ENVIRONMENT AND DISEASE CHARACTERISTICS DETERMINE THE OUTCOME OF TREATMENT
由: L. Frölich, et al.
出版: (2022-06-01)

Identifying Early Infections in the Setting of CRS With Routine and Exploratory Serum Proteomics and the HT10 Score Following CD19 CAR-T for Relapsed/Refractory B-NHL
由: Kai Rejeski, et al.
出版: (2023-04-01)

Prognostic significance of immune reconstitution following CD19 CAR T‐cell therapy for relapsed/refractory B‐cell lymphoma
由: Sophia Stock, et al.
出版: (2025-01-01)

Clinicopathologic Findings in Fatal Neurotoxicity After Adoptive Immunotherapy With CD19-Directed CAR T-Cells
由: Philipp Karschnia, et al.
出版: (2021-03-01)

The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma
由: Kai Rejeski, et al.
出版: (2023-07-01)

Efficacy and safety of bendamustine‐containing bridging therapy in R/R LBCL patients receiving CD19 CAR T‐cells
由: Gloria Iacoboni, et al.
出版: (2024-07-01)

Thrombopoietin receptor agonists for acquired thrombocytopenia following anti-CD19 CAR-T-cell therapy: a case report
由: Regina Jitschin, et al.
出版: (2021-07-01)

P12.02 Adaptor P329G-directed CAR T cells for modular targeting of AML
由: C Klein, et al.
出版: (2024-03-01)

Budget Impact Analysis of CAR T-cell Therapy for Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma in Germany
由: Daniela Skalt, et al.
出版: (2022-07-01)

Development and validation of the post-CAR prognostic index for large B-cell lymphoma patients after CAR-T progression in third or later line treatment
由: Gloria Iacoboni, et al.
出版: (2024-10-01)

Cars, cars and more cars [kasetvideo]
出版: ([197)

Hematologic Rescue of CAR T-cell–mediated Prolonged Pancytopenia Using Autologous Peripheral Blood Hematopoietic Stem Cells in a Lymphoma Patient
由: Philipp Gödel, et al.
出版: (2021-03-01)

A tale of excess: the curious case of the woman with 1447 emergency visits
由: M. Sagué Vilavella, et al.
出版: (2023-03-01)

Chimeric Antigen Receptor T-cell Therapy: Imaging Response Criteria and Relation to Progression-free and Overall Survival
由: Michael Winkelmann, et al.
出版: (2022-10-01)

Increased visceral fat distribution and body composition impact cytokine release syndrome onset and severity after CD19 chimeric antigen receptor T-cell therapy in advanced B-cell malignancies
由: David M. Cordas dos Santos, et al.
出版: (2022-02-01)

Sustained Remission of Relapsed Diffuse Large B-cell Lymphoma After Safe Administration of CD19-directed CAR T-cells in a Patient With Chronic Intestinal and Pulmonal GvHD
由: Nadine Kutsch, et al.
出版: (2022-07-01)

Modification of Lugano criteria by pre-infusion tumor kinetics improves early survival prediction for patients with lymphoma under chimeric antigen receptor T-cell therapy
由: Christian Schmidt, et al.
出版: (2023-10-01)

P1163: OUTCOMES OF HIGH-RISK LARGE B-CELL LYMPHOMA TREATED WITH STANDARD OF CARE CHEMOIMMUNOTHERAPY: A NON-RANDOMIZED COMPARISON TO FRONTLINE CAR-T CELL THERAPY
由: O. Albanyan, et al.
出版: (2022-06-01)

Mirza Şahruh Zamanında (1405 - 1447) Timurlularda İmar Faaliyetleri
由: İsmail Aka
出版: (1984-04-01)

Die Urkunde von Veletiny aus dem J. 1447
由: Ivan Hlaváček
出版: (2015-02-01)

CAR T-Cell Therapy: Paving the Path to a Brighter Future in LBCL
由: Frederick Locke
出版: (2023-03-01)

Development of Auto Car Jack Using Internal Car Power
由: M. M., Noor, et al.
出版: (2008)

An International Survey on Grading, Diagnosis, and Management of Immune Effector Cell-Associated Hematotoxicity (ICAHT) Following CAR T-cell Therapy on Behalf of the EBMT and EHA
由: Kai Rejeski, et al.
出版: (2023-05-01)

S287: FACTORS INFLUENCING AUTOLOGOUS LYMPHOCYTE COLLECTIONS FOR CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS – THE ROLE OF T-CELL SENESCENCE
由: V. Vucinic, et al.
出版: (2022-06-01)

Plastics in cars/
由: Welling, M. S.
出版: (1983)

CAR-T Regulatory (CAR-Treg) Cells: Engineering and Applications
由: Motahareh Arjomandnejad, et al.
出版: (2022-01-01)

Car electrics /
由: Rosewarne, M. H.
出版: (1971)

Car maintenance/
由: 292990 Crawley, M. C.
出版: (1978)

A gliding car
由: Mohamed Sharfudeen S/O Pathiujjamman
出版: (2024)

International comparisons of cars and car useage/
由: 400835 Tanner, J. C., et al.
出版: (1983)

Car-to-car communication for energy efficiency
由: Tarn, Willis Rui Seng.
出版: (2012)

Broadcasting data for car-to-car communication
由: Ang, Hui Chen
出版: (2016)

Estimation of losses from damage of cars
由: M.V. Gnenniy, et al.
出版: (2012-04-01)

Optimizing Real-World Outcomes in High-Risk Relapsed/Refractory (r/r) DLBCL with CAR T Cell Therapy: A Vodcast and Case Example
由: Gloria Iacoboni, et al.
出版: (2024-12-01)

VINTAGE & VETERAN CAR ENCYCLOPAEDIA : SPORTS CARS AND PASSENGER CARS 1886-1940 /
由: Rive Box, Rob de la, author, et al.
出版: (2000)

S260: IMMUNE EFFECTOR CELL ASSOCIATED HEMATOTOXICITY (ICAHT) FOLLOWING CAR T-CELL THERAPY: INTERNATIONAL SURVEY AND CONSENSUS GUIDELINES ON ITS GRADING, DIAGNOSIS, AND MANAGEMENT ON BEHALF OF EHA AND EBMT
由: Kai Rejeski, et al.
出版: (2023-08-01)